InterventionsHuman trial
Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial
ADA Scientific Sessions 2026 Abstract
The paper
Lawrence Leiter, Nicholas Marston, Gaetano M. De Ferrari, Erin Ann Bohula
Show 17 more authors
José Carlos Nicolau, Gabriel Paiva da Silva Lima, Ajay K. Bhatia, Marcoli Cyrille, Jeong-Gun Park, Julia Kuder, Sabina Murphy, Lyrica Liu, Huei Wang, Andrej Džupina, Jorge Ferreira, Ioanna Gouni-Berthold, Henrik K. Jensen, Naveed Sattar, Dragoş Vinereanu, Robert Patrick Giugliano, Marc Steven Sabatine,Toronto
ADA Scientific Sessions 2026 Abstract · 7 Jun 2026
Presented at ADA Scientific Sessions 2026 · Oral 1247-OR